20-44626579-T-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BS2_SupportingBA1

This summary comes from the ClinGen Evidence Repository: The NM_000022.4:c.239A>G variant in ADA is a missense variant predicted to cause substitution of lysine by arginine at amino acid 80 (p.Lys80Arg). The Popmax filtering allele frequency of this variant in the gnomAD v2.1.1 database is 0.06430, which is higher than the ClinGen SCID VCEP threshold (>0.00721) for BA1 (BA1). This variant has been observed in 551 homozygous individuals with no feature of SCID, a condition with full penetrance at an early age (BS2_Supporting). In summary, this variant meets the criteria to be classified as benign for SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA251993/MONDO:0007064/114

Frequency

Genomes: 𝑓 0.059 ( 274 hom., cov: 32)
Exomes 𝑓: 0.060 ( 2916 hom. )

Consequence

ADA
NM_000022.4 missense

Scores

4
13

Clinical Significance

Benign reviewed by expert panel U:1B:11

Conservation

PhyloP100: 3.06

Publications

27 publications found
Variant links:
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
ADA Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000022.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADA
NM_000022.4
MANE Select
c.239A>Gp.Lys80Arg
missense
Exon 4 of 12NP_000013.2
ADA
NM_001322051.2
c.239A>Gp.Lys80Arg
missense
Exon 4 of 11NP_001308980.1F5GWI4
ADA
NM_001322050.2
c.-51A>G
5_prime_UTR
Exon 4 of 11NP_001308979.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADA
ENST00000372874.9
TSL:1 MANE Select
c.239A>Gp.Lys80Arg
missense
Exon 4 of 12ENSP00000361965.4P00813
ADA
ENST00000537820.2
TSL:1
c.239A>Gp.Lys80Arg
missense
Exon 4 of 11ENSP00000441818.1F5GWI4
ADA
ENST00000695995.1
c.216+2470A>G
intron
N/AENSP00000512318.1A0A8Q3SI64

Frequencies

GnomAD3 genomes
AF:
0.0587
AC:
8925
AN:
152170
Hom.:
274
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0656
Gnomad AMI
AF:
0.0537
Gnomad AMR
AF:
0.0476
Gnomad ASJ
AF:
0.0844
Gnomad EAS
AF:
0.00231
Gnomad SAS
AF:
0.0584
Gnomad FIN
AF:
0.0355
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0634
Gnomad OTH
AF:
0.0636
GnomAD2 exomes
AF:
0.0574
AC:
14437
AN:
251426
AF XY:
0.0587
show subpopulations
Gnomad AFR exome
AF:
0.0640
Gnomad AMR exome
AF:
0.0601
Gnomad ASJ exome
AF:
0.0827
Gnomad EAS exome
AF:
0.00142
Gnomad FIN exome
AF:
0.0381
Gnomad NFE exome
AF:
0.0655
Gnomad OTH exome
AF:
0.0642
GnomAD4 exome
AF:
0.0602
AC:
87946
AN:
1461798
Hom.:
2916
Cov.:
32
AF XY:
0.0605
AC XY:
44028
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.0700
AC:
2344
AN:
33480
American (AMR)
AF:
0.0593
AC:
2654
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0805
AC:
2103
AN:
26134
East Asian (EAS)
AF:
0.000630
AC:
25
AN:
39690
South Asian (SAS)
AF:
0.0591
AC:
5098
AN:
86254
European-Finnish (FIN)
AF:
0.0421
AC:
2248
AN:
53406
Middle Eastern (MID)
AF:
0.114
AC:
656
AN:
5736
European-Non Finnish (NFE)
AF:
0.0619
AC:
68875
AN:
1111982
Other (OTH)
AF:
0.0653
AC:
3943
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
5326
10652
15978
21304
26630
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2514
5028
7542
10056
12570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0586
AC:
8928
AN:
152288
Hom.:
274
Cov.:
32
AF XY:
0.0571
AC XY:
4251
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0656
AC:
2726
AN:
41560
American (AMR)
AF:
0.0476
AC:
728
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0844
AC:
293
AN:
3470
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5172
South Asian (SAS)
AF:
0.0585
AC:
282
AN:
4824
European-Finnish (FIN)
AF:
0.0355
AC:
377
AN:
10624
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0634
AC:
4310
AN:
68014
Other (OTH)
AF:
0.0634
AC:
134
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
432
865
1297
1730
2162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0631
Hom.:
760
Bravo
AF:
0.0608
TwinsUK
AF:
0.0599
AC:
222
ALSPAC
AF:
0.0631
AC:
243
ESP6500AA
AF:
0.0681
AC:
300
ESP6500EA
AF:
0.0635
AC:
546
ExAC
AF:
0.0588
AC:
7145
Asia WGS
AF:
0.0380
AC:
130
AN:
3478
EpiCase
AF:
0.0682
EpiControl
AF:
0.0692

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
5
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency (6)
-
-
4
not specified (4)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
18
DANN
Benign
0.97
DEOGEN2
Uncertain
0.66
D
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.40
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.0050
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.21
N
PhyloP100
3.1
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.0
N
REVEL
Uncertain
0.29
Sift
Benign
0.36
T
Sift4G
Benign
0.44
T
Polyphen
0.0010
B
Vest4
0.16
MPC
0.12
ClinPred
0.012
T
GERP RS
2.6
Varity_R
0.073
gMVP
0.54
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11555566; hg19: chr20-43255220; COSMIC: COSV65739876; COSMIC: COSV65739876; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.